{"id":4583,"date":"2023-07-25T13:12:56","date_gmt":"2023-07-25T13:12:56","guid":{"rendered":"https:\/\/wapcpharm.org\/journal\/?p=4583"},"modified":"2023-07-28T13:27:57","modified_gmt":"2023-07-28T13:27:57","slug":"west-african-journal-of-pharmacy-2017-28-2-26-34","status":"publish","type":"post","link":"https:\/\/wapcpharm.org\/journal\/west-african-journal-of-pharmacy-2017-28-2-26-34\/","title":{"rendered":"West African Journal of Pharmacy (2017) 28 (2) 35-51"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"4583\" class=\"elementor elementor-4583\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-4d870b4 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4d870b4\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7c17d5c4\" data-id=\"7c17d5c4\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-55644500 elementor-widget elementor-widget-text-editor\" data-id=\"55644500\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: center;\"><b>Impurities profiling of brands of ceftriaxone sodium injection marketed in Ibadan, Southwest Nigeria<\/b><\/p><p style=\"text-align: center;\">\u00a0<\/p><p style=\"text-align: center;\">Olajire A. Adegoke , Aderonke O. Korede , Adosraku R. Kwame and Cecilia I. Igwilo<\/p><p style=\"text-align: center;\">1<span style=\"font-size: 19px; color: var( --e-global-color-text );\">Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria,<\/span><\/p><p style=\"text-align: center;\">2Multidisciplinary Central Research Laboratory, University of Ibadan, Ibadan, Nigeria,<\/p><p style=\"text-align: center;\">3<span style=\"font-size: 19px; color: var( --e-global-color-text );\">Department of Pharmaceutical Chemistry, Faculty of Pharmacy &amp; Pharm. Sciences,\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">Kwame Nkrumah University of Science and Technology, Kumasi, Ghana;<\/span><\/p><p style=\"text-align: center;\">4<span style=\"font-size: 19px; color: var( --e-global-color-text );\">Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, University of Lagos, Nigeria<\/span><\/p><p style=\"text-align: center;\">\u00a0<\/p><p style=\"text-align: center;\">Correspondence author: Olajire A. Adegoke<\/p><p style=\"text-align: center;\">Emails: jireade@yahoo.com Phone: +2348036381625<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-3ee6dfd0 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"3ee6dfd0\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7cb1a333\" data-id=\"7cb1a333\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-6795b127 elementor-widget elementor-widget-heading\" data-id=\"6795b127\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">ABSTRACT<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7e22f0b7 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7e22f0b7\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-7b20f27a\" data-id=\"7b20f27a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-189eda48 elementor-widget elementor-widget-text-editor\" data-id=\"189eda48\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p style=\"text-align: justify;\"><b>Background:<\/b> Several factors can affect the effectiveness of a drug in therapy. One of such is the presence of <span style=\"font-size: 19px; color: var( --e-global-color-text );\">impurities.<\/span><\/p><p style=\"text-align: justify;\"><b>Objectives:<\/b> Based on the current useful utility status of ceftriaxone injection as an antibacterial agent, a\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">comprehensive impurity profiling of thirteen brands was carried out in order to provide a basis for specifying\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">appropriate storage conditions.<\/span><\/p><p style=\"text-align: justify;\"><b>Methods: <\/b>The profiling was carried out by developing a new liquid chromatographic method with UV\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">detection. Factors that could affect the separation method such as elution mode, pH, flow rate, detection\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">wavelength and type of organic modifier were studied. Validation studies comprising calibration curve, LOD\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">and LOQ determination, accuracy and repeatability were determined. The method was successfully applied\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">to the determination of ceftriaxone and impurities in 13 brands of ceftriaxone injections.<\/span><\/p><p style=\"text-align: justify;\"><b>Results: <\/b>The developed method involved separation of ceftriaxone and major impurities within 15 minutes\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">using gradient elution with KH PO (pH 7.5) and methanol (flow rate, 1 mL\/min). Separation was achieved on 2 4\u00a0<\/span><span style=\"color: var( --e-global-color-text ); font-size: 19px;\">2\u00a0<\/span><span style=\"color: var( --e-global-color-text ); font-size: 19px;\">a C-18 column at 220 nm. Linearity was obtained within the range 7.8 \u2013 250 \u03bcg\/mL (r = 0.9996) with LOD and\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">LOQ as 74.56 and 225.9 ng\/mL respectively. Relative errors from the intra- and inter-day assessment were\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">generally less than 2%. All the brands complied with the content BP specification of 92-108% of ceftriaxone.\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">However, the impurities content in all the 13 brands were far higher than the 0.2% specified by ICH for the\u00a0<\/span><span style=\"font-size: 19px; color: var( --e-global-color-text );\">dose of the drug.<\/span><\/p><p style=\"text-align: justify;\"><b>Conclusion:<\/b> There is need for measures to adequately control storage conditions of the injection in order to\u00a0<span style=\"font-size: 19px; color: var( --e-global-color-text );\">limit impurities content.<\/span><\/p><p style=\"text-align: justify;\"><b>Keywords:<\/b> Ceftriaxone, Impurities profiling, Liquid chromatography, Storage conditions<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-394903e6 elementor-align-right elementor-widget elementor-widget-button\" data-id=\"394903e6\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/wapcpharm.org\/journal\/wp-content\/uploads\/2023\/07\/Chapter-5-1_compressed-2.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-text\">Download <\/span>\n\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Impurities profiling of brands of ceftriaxone sodium injection marketed in Ibadan, Southwest Nigeria \u00a0 Olajire A. Adegoke , Aderonke O. Korede , Adosraku R. Kwame and Cecilia I. Igwilo 1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria, 2Multidisciplinary Central Research Laboratory, University of Ibadan, Ibadan, Nigeria, 3Department of Pharmaceutical Chemistry, Faculty [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[233],"tags":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4583"}],"collection":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/comments?post=4583"}],"version-history":[{"count":5,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4583\/revisions"}],"predecessor-version":[{"id":4597,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/posts\/4583\/revisions\/4597"}],"wp:attachment":[{"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/media?parent=4583"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/categories?post=4583"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wapcpharm.org\/journal\/wp-json\/wp\/v2\/tags?post=4583"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}